tiprankstipranks
Trending News
More News >
Vita Life Sciences Limited (AU:VLS)
ASX:VLS
Australian Market

Vita Life Sciences Limited (VLS) Price & Analysis

Compare
12 Followers

VLS Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.61%97.39%
Mutual Funds
― Other Institutional Investors
97.39% Public Companies and
Individual Investors

VLS FAQ

What was Vita Life Sciences Limited’s price range in the past 12 months?
Vita Life Sciences Limited lowest share price was AU$1.62 and its highest was AU$2.38 in the past 12 months.
    What is Vita Life Sciences Limited’s market cap?
    Vita Life Sciences Limited’s market cap is AU$121.95M.
      When is Vita Life Sciences Limited’s upcoming earnings report date?
      Vita Life Sciences Limited’s upcoming earnings report date is Aug 21, 2025 which is in 59 days.
        How were Vita Life Sciences Limited’s earnings last quarter?
        Vita Life Sciences Limited released its earnings results on Feb 23, 2025. The company reported AU$0.08 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.08.
          Is Vita Life Sciences Limited overvalued?
          According to Wall Street analysts Vita Life Sciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Vita Life Sciences Limited pay dividends?
            Vita Life Sciences Limited pays a Semiannually dividend of AU$0.099 which represents an annual dividend yield of 5.88%. See more information on Vita Life Sciences Limited dividends here
              What is Vita Life Sciences Limited’s EPS estimate?
              Vita Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Vita Life Sciences Limited have?
              Vita Life Sciences Limited has 55,180,676 shares outstanding.
                What happened to Vita Life Sciences Limited’s price movement after its last earnings report?
                Vita Life Sciences Limited reported an EPS of AU$0.08 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.738%.
                  Which hedge fund is a major shareholder of Vita Life Sciences Limited?
                  Currently, no hedge funds are holding shares in AU:VLS

                  Vita Life Sciences Limited Stock Smart Score

                  Company Description

                  Vita Life Sciences Limited

                  Vita Life Sciences Limited (VLS) is a pharmaceuticals and healthcare company that specializes in the development, marketing, and distribution of a wide range of health and wellness products. With a focus on improving human health, VLS operates primarily in the nutraceuticals sector, offering an array of vitamins, minerals, supplements, and over-the-counter pharmaceuticals. The company is known for its commitment to research and development, ensuring that its products meet high-quality standards and address various health needs.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cynata Therapeutics Limited
                  Botanix Pharmaceuticals Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis